Uveal cancer is a rare eye cancer that starts in the middle layer of the eye, and it mostly affects adults. Early symptoms of uveal cancer can include blurry vision, flashes, floaters, or a dark spot in vision, but some people have no symptoms at first. It may help to know that doctors have studied this condition for decades, and treatment often includes radiation, laser treatment, surgery, or careful monitoring in selected cases. Uveal cancer can be treated, but some tumors spread to other parts of the body, especially the liver, and this can become life-threatening. Not everyone will have the same experience, and outlook depends on the size of the tumor, where it is in the eye, and whether uveal cancer has spread.
How many people live with Uveal cancer?
Worldwide, roughly 35,000 to 45,000 people may be living with uveal cancer, estimated from GLOBOCAN’s count of people living within 5 years of an eye cancer diagnosis and the fact that uveal cancer makes up about 80% to 90% of adult eye cancers (Global Cancer Observatory, 2022). In the United States, the same approach suggests about 9,000 to 11,000 people (Global Cancer Observatory, 2022). These are estimates rather than direct counts.
Overview
Uveal cancerSymptoms
Uveal cancer often causes no early symptoms. As it grows, people may notice blurred vision, flashes, floaters, or a dark spot in sight. Some also develop partial vision loss or a change in pupil shape.
Outlook and prognosis
Outlook for uveal cancer varies by tumor size, location, and whether it has spread. Many people do well after treatment, especially when it is found early. Ongoing eye exams and body scans help watch for vision changes and spread.
Causes and risk factors
Uveal cancer often starts from DNA changes in pigment-making eye cells. Risk is higher with older age, light eye color, fair skin, certain inherited gene changes, and some unusual eye or skin spots. Most cases are not caused by lifestyle.
Genetic influences
Genetics matter a lot in uveal cancer. Most cases are not inherited, but gene changes in the tumor help predict how it may behave and guide follow-up. Rarely, inherited changes can raise risk.
Diagnosis
Doctors diagnose uveal cancer with an eye exam, imaging, and often photos of the inside of the eye. If needed, scans of the liver or other areas check for spread. The diagnosis of uveal cancer may also involve biopsy.
Treatment and drugs
Treatment for uveal cancer depends on the tumor’s size, location, and whether it has spread. Many people are treated with targeted eye radiation, laser therapy, or surgery. If uveal cancer spreads, care may include liver-directed treatment, immunotherapy, or clinical trials.
Symptoms
Uveal cancer often affects sight before it causes pain, so day to day it may show up as blurry areas, new floaters, or trouble seeing off to one side. You might notice small changes at first, and some people have no symptoms until an eye exam picks it up. Early symptoms of uveal cancer can be easy to mistake for common eye problems, especially if they come on slowly. Symptoms vary with the tumor's size and where it grows inside the eye.
Vision may become blurry in one eye or seem harder to focus, especially if the tumor affects the light-sensitive lining at the back of the eye. Reading, driving, or recognizing faces may take more effort than usual.
Some people notice brief flashes of light or new floating specks drifting across their vision. These changes can have other causes too, but a sudden or worsening change should be checked promptly.
A dark patch, shadow, or loss of side vision can develop if part of the retina is affected. This may show up as missing parts of words while reading or not seeing objects off to one side.
A new dark spot on the colored part of the eye may be visible, especially when uveal cancer starts in the iris. The spot can slowly enlarge or change shape over time.
How people usually first notice Uveal cancer?
Uveal cancer often stays quiet at first, so many people do not notice anything until an eye exam picks up a suspicious spot inside the eye. When symptoms do appear, the first warning signs of uveal cancer are often blurred vision, flashes of light, new floaters, a growing dark area in vision, or a change in the shape or look of the eye. Because these changes can also happen with less serious eye problems, the key practical takeaway is that any new, persistent vision change should be checked promptly by an eye doctor.
Types of Uveal cancer
Uveal cancer can affect different parts of the eye, and where it starts often shapes what people notice day to day. The main types of uveal cancer are grouped by location in the uvea, the middle layer of the eye, so symptoms and exam findings can vary quite a bit. Symptoms don’t always look the same for everyone. Some tumors are found during a routine eye exam, while others cause blurred vision, flashes, or a dark spot in vision.
Iris melanoma
This type starts in the colored part of the eye and is often easier to see than other forms of uveal cancer. Many people notice a dark spot on the iris or a change in the shape of the pupil, and it may grow slowly. Vision may stay normal for a long time, especially when the tumor is small.
Ciliary body melanoma
This type begins in a ring-shaped structure just behind the iris, so it can stay hidden at first. Some may find it causes blurred vision, eye pressure problems, or a change in the lens position before anything is visible from the outside. It is often found later than iris melanoma because early symptoms can be mild or absent.
Choroidal melanoma
This is the most common of the types of uveal cancer and starts in the layer beneath the retina at the back of the eye. People with this type may notice blurry vision, flashes of light, floaters, or a shadow in part of their sight. Small tumors may cause no symptoms and are sometimes picked up only during a dilated eye exam.
Can I slow down the onset of symptoms?
Probably not: there is no proven lifestyle change or medicine that can meaningfully delay the start of uveal cancer, and many people with this eye cancer have no symptoms at first. Research on things like sun exposure is still limited, so healthy habits are good for overall health but have not been shown to prevent uveal cancer or reliably postpone symptoms. Regular dilated eye exams, especially for people with a spot in the eye or a family history, cannot stop it from developing but may find it earlier, before vision changes begin, which is a practical step worth taking.
What genetics can tell you about symptoms
In uveal cancer, genetics can sometimes give clues about how the cancer may behave, but they usually do not predict exactly which symptoms someone will notice day to day. For many living with this cancer, symptoms such as blurred vision, flashes, floaters, or vision loss depend more on where the tumor is in the eye and how large it is than on the tumor’s gene changes. Some genetic changes are linked to a higher chance of faster growth or spread and may be associated with a more serious course, but they are less helpful for predicting the exact symptoms or when those symptoms will begin.
Causes and risk factors
For many living with uveal cancer, there is no single clear cause. Most cases begin when pigment cells inside the eye develop gene changes over time, and a family history or rare inherited gene changes can also raise risk. Older age, light-colored eyes, fair skin, and certain pigment conditions of the eye are among the better known risk factors for uveal cancer. It’s rarely just one factor—it’s the mix that matters. Unlike skin melanoma, sunlight has not been clearly proven to cause uveal cancer, and no strong lifestyle cause has been confirmed.
What are the most common causes or risk factors?
The exact cause of uveal cancer, which starts in the middle layer of the eye, is usually not known, and most cases are not caused by anything you did. It is seen more often in older adults, especially people with light-colored eyes and fair skin. Risk can also be higher in people born with certain gene changes or rare family cancer conditions, and in those who have unusual pigment spots or extra pigment in or around the eye.
Environmental and biological risk factors
Because uveal cancer can start quietly, it helps to know which factors make it more likely. Most known risks for uveal cancer are biological rather than environmental, and no single outside cause has been firmly proven. Being exposed to risks in your body or environment doesn’t mean illness is inevitable. The clearest risk factors for uveal cancer include older age, lighter natural pigmentation, and certain pigmented spots or conditions in the eye.
Uveal cancer becomes more common as people get older, especially from midlife onward. It can happen in younger adults, but that is less common.
People with blue, gray, or green eyes develop uveal cancer more often than people with brown eyes. Lower natural pigment in the eye may play a role, although the exact reason is not fully understood.
Fair skin or light hair is linked with a higher risk of uveal cancer, especially when light-colored eyes are also present. This does not mean these features will cause cancer, only that they are associated with higher risk.
Extra pigment cells in the white of the eye, deeper eye tissues, or nearby skin can raise risk. This uncommon condition is one of the strongest known biological risk factors for uveal cancer.
Genetic risk factors
For many living with uveal cancer, the hardest part can be not knowing why it developed. Most cases are linked to gene changes that start in the pigment cells inside the eye during life, rather than to a condition that was passed down through a family. A smaller number are tied to inherited changes, especially BAP1, so understanding the genetic risk factors for uveal cancer can help guide family history review and testing. Carrying a genetic change doesn’t guarantee the condition will appear.
Acquired mutations: Most uveal cancers begin after gene changes develop in eye pigment cells, usually in genes such as GNAQ or GNA11. These changes are usually not inherited, so they are not typically passed from parent to child.
BAP1 syndrome: An inherited change in the BAP1 gene is the best-known hereditary risk factor for uveal cancer. Families with this syndrome may also have higher rates of mesothelioma, kidney cancer, or skin melanoma.
Family history: Uveal cancer does not often run strongly in families, but having a close relative with it can raise concern for an inherited risk. This matters even more if several relatives have BAP1-related cancers or developed cancer at younger ages.
Rare gene changes: Rare inherited changes in genes such as MBD4 have also been linked to uveal cancer in some families. These are uncommon and do not explain most cases.
Light eye color: People born with blue, gray, or green eyes have a higher chance of uveal cancer than those with darker eyes. This likely reflects inherited differences in pigment biology, but eye color alone is not enough to cause cancer.
Lifestyle risk factors
The evidence for lifestyle risk factors for uveal cancer is limited compared with many other cancers. There are no firmly established habits that clearly cause most cases, but some behaviors may still influence overall cancer health, treatment tolerance, and recovery. When people ask about lifestyle risk factors for uveal cancer, it is important to know that research is still evolving and most links are weaker than for lung, colon, or skin cancers.
Smoking is not a proven major cause of uveal cancer, but it can increase oxidative stress and may worsen overall cancer health. It can also reduce healing capacity and raise the risk of treatment complications.
Heavy alcohol use has not been clearly established as a direct cause of uveal cancer. However, it can impair liver health, which matters because the liver is a common site where uveal cancer can spread.
No specific diet has been proven to prevent or trigger uveal cancer. A diet high in ultra-processed foods and low in nutrient-dense foods may promote inflammation and poorer overall health during cancer care.
Lack of exercise is not a confirmed direct cause of uveal cancer. Still, regular activity can support metabolic health, energy levels, and recovery during and after treatment.
Risk prevention
For most people, there is no sure way to prevent uveal cancer, because many of its risk factors cannot be changed. Prevention is about lowering risk, not eliminating it completely. The most practical steps focus on protecting the eyes from avoidable harm, knowing whether you have higher-than-average risk, and catching problems early through eye care.
Wearing sunglasses that block 99% to 100% of UVA and UVB rays and using a wide-brimmed hat may help reduce unnecessary ultraviolet exposure. The link between UV light and uveal cancer is not fully settled, but protecting your eyes is a sensible low-risk habit.
If you work around welding arcs, strong lamps, or other intense light sources, use proper protective eyewear every time. This helps limit eye injury and light exposure that could add stress to delicate tissues inside the eye.
Dilated eye exams can sometimes find uveal cancer before it causes major problems with sight. Because early symptoms of uveal cancer can be easy to miss, routine eye care is especially important if you have vision changes or have been told you are at higher risk.
Some people have a higher chance of uveal cancer because of light-colored eyes, certain unusual moles in or around the eye, or inherited conditions that affect pigment cells. Knowing your risks can guide which preventive steps matter most.
Can you prevent Uveal cancer?
There is no sure way to prevent uveal cancer, which is a rare cancer that starts inside the eye, because most known risk factors such as age, lighter eye color, and inherited traits cannot be changed. Wearing sunglasses that block UV rays is a sensible way to protect overall eye health, but it has not been clearly proven to prevent this cancer.
Transmission
Uveal cancer is not infectious, so you cannot catch it from someone else through everyday contact. Living in the same home, sharing meals, hugging, kissing, or being near someone with uveal cancer does not spread it.
Most uveal cancer is also not passed from parent to child. When people ask how uveal cancer is inherited, the answer is that family transmission is rare; a small number of cases are linked to inherited gene changes, but most happen because of changes that develop in the eye cells over time.
When to test your genes
For uveal cancer, genetic testing is usually most useful after diagnosis, because testing the tumor can estimate the risk of spread and help tailor follow-up. Inherited gene testing may also be worth discussing if you have a strong family history of uveal melanoma, mesothelioma, kidney cancer, or multiple unusual melanomas, especially at younger ages.
Diagnosis
Uveal cancer is usually found after vision changes, a dark spot in the eye, or an eye exam shows something unusual. The diagnosis of uveal cancer often starts with a close look inside the eye, then imaging tests help confirm what the doctor sees. It’s natural to worry when symptoms don’t have a clear explanation.
An eye specialist checks your vision, pupils, and eye pressure, then looks for changes that could point to a tumor. A dilated eye exam helps them see the back of the eye more clearly.
Using bright lights and special lenses, the doctor examines the uvea and nearby structures for the size, shape, and location of the growth. These features can strongly suggest uveal cancer without surgery.
Ultrasound uses sound waves to show the thickness and internal pattern of the tumor. This is one of the most important tests for confirming how uveal cancer is diagnosed.
Photos and scans such as optical coherence tomography can show fluid, retinal changes, or lifting of tissues around the tumor. These imaging findings help tell uveal cancer apart from some harmless eye spots.
How is Uveal cancer diagnosed?
Uveal cancer is usually diagnosed by an eye specialist after a careful eye exam with drops to widen the pupil and imaging tests that create detailed pictures of the inside of the eye, often including ultrasound and special camera scans. In many people, the look of the tumor on the exam and scans is enough to make the diagnosis, so a biopsy, which means taking a small sample of cells, is not always needed. If the findings are not clear, or if doctors want more information about how the cancer may behave, they may test a small sample of the tumor for gene changes, but this is usually not the main way the cancer is first found.
Stages of Uveal cancer
Uveal cancer is usually described in stages based on the size of the tumor, whether it involves nearby parts of the eye, and whether it has spread elsewhere in the body. In day-to-day life, this staging helps people understand what treatment may involve and how closely follow-up is needed. Sometimes the early symptoms of uveal cancer are subtle, so the stage is often worked out with detailed eye exams and scans rather than symptoms alone. Many people feel reassured knowing what their tests can—and can’t—show.
Stage 1
The tumor is small and limited to the eye. Many people with uveal cancer have few symptoms at this stage, and it may be found during a routine eye exam.
Stage 2
The tumor is larger but is still mainly confined to the eye. Some may notice blurred vision, flashes, floaters, or a dark spot in vision, although others still feel well.
Stage 3
The cancer is more advanced in or around the eye. It may affect nearby eye structures or extend outside the eyeball, which can raise the chance of pain, vision loss, or visible changes in the eye.
Stage 4
The cancer has spread to another part of the body, most often the liver. At this stage, care usually includes tests beyond the eye and treatment aimed at both the eye tumor and the spread elsewhere.
Outlook and prognosis
The outlook for uveal cancer depends mainly on tumor size, location, cell type, and whether the cancer has spread beyond the eye. Many people with disease confined to the eye are successfully treated with radiation, laser therapy, or surgery, and local tumor control is often high, but vision loss can still occur depending on the treatment and tumor position. The main long-term concern is metastasis, especially to the liver, which can develop years after the original eye tumor is treated, so lifelong follow-up is usually recommended. Smaller tumors and earlier diagnosis are generally linked to a better prognosis, while certain genetic changes in the tumor are associated with a higher risk of spread. Mortality is driven largely by metastatic disease rather than the eye tumor itself, and once uveal melanoma has spread, survival is often significantly reduced despite newer systemic treatments. Overall, prognosis ranges from very good for localized low-risk tumors to guarded for high-risk or metastatic cases.
Long-term effects
For many people, the biggest long-term effects of uveal cancer relate to vision, ongoing monitoring, and the chance that the cancer may return or spread. Some may find that daily tasks change over time, especially if treatment affects one eye more than the other. Thinking about the long-term effects helps set realistic expectations, because outcomes can vary with the tumor size, where it started in the eye, and whether it has spread.
Treatment for uveal cancer can leave lasting changes in sight, such as blurred vision, blind spots, reduced side vision, or trouble judging depth. For many, this can mean needing more time for reading, driving, or moving around unfamiliar places.
Some people develop long-term eye problems after treatment, including dryness, irritation, cataracts, high eye pressure, or damage to the retina. These changes may appear slowly months or years later and can sometimes cause ongoing discomfort or further vision loss.
If the eye has to be removed, long-term effects can include permanent loss of vision on that side and changes in depth perception. Many living with uveal cancer also notice practical adjustments in daily routines, along with changes in appearance that can affect confidence and comfort in social settings.
The most serious long-term concern is that uveal cancer can spread, most often to the liver, sometimes years after the original eye tumor was treated. When this happens, it can cause fatigue, weight loss, belly discomfort, or abnormal liver tests, although early spread may cause no symptoms at first.
How is it to live with Uveal cancer?
Living with uveal cancer can feel unsettling because it touches both your health and something as central as vision, and daily life may shift quickly around medical visits, scans, treatment decisions, and the emotional weight of uncertainty. Some people notice changes in sight, depth perception, or comfort in the affected eye, while others feel physically well but still carry the strain of frequent monitoring because this cancer can sometimes spread, most often to the liver. For many, this can mean adjusting work, driving, reading, and other routines, while family and close friends often take on extra roles such as transportation, practical help, and emotional support. The hard part is real, but many living with uveal cancer find that clear information, specialist follow-up, and support from the people around them can help life feel steadier and more manageable.
Treatment and drugs
Treatment for uveal cancer depends mainly on the size and location of the tumor and whether it has spread, and the goal is to control the cancer while protecting as much vision as possible. Some people are treated with focused radiation, which is often used for small to medium tumors, while others may need laser treatment, surgery, or removal of the eye if the cancer is large or causing pain. Treatment often looks different for each person, because doctors also consider vision in the other eye, overall health, and how likely the tumor is to grow or return. If the cancer has spread outside the eye, treatment may include medicines that treat cancer throughout the body, and care is usually guided by a cancer specialist. After treatment, regular follow-up visits are important because uveal cancer can come back or spread later, even when the eye problem itself seems stable.
Can you cure Uveal cancer?
There is no guaranteed cure for uveal cancer, but some people can be cured if it is found early and treated before it spreads outside the eye. Treatment may use radiation, laser treatment, surgery, or medicine to destroy or remove the cancer, protect as much sight as possible, and lower the chance of it coming back or spreading. If the cancer has already spread, treatment usually aims to control it and ease symptoms rather than cure it.
Non-drug treatment
Treatment for uveal cancer is usually aimed at controlling the tumor while protecting as much vision and comfort as possible. The best choice often depends on where the tumor sits in the eye, how large it is, and whether it has spread. For many, treatment begins not at the pharmacy, but with focused procedures such as radiation or surgery. Because treatment options for uveal cancer can differ a lot from one person to another, care is often planned by an eye cancer team.
This is one of the most common treatments for uveal cancer. A small radiation disc is placed on the outside of the eye for several days so it can target the tumor directly. Many people go home with the plaque in place and return later to have it removed.
Proton beam treatment uses a very precise form of radiation to treat the tumor while limiting damage to nearby tissue. It may be especially helpful when the cancer is close to important structures in the eye. Treatment is usually given over several visits.
Heat-based laser treatment may be used for some small tumors or along with radiation. It is not right for every case, but it can help shrink or control selected tumors. Not every approach works the same way for all types and sizes of uveal cancer.
In some cases, surgeons can remove the tumor while leaving the eye in place. This is less common than radiation and is usually considered only in carefully selected situations. Recovery and visual results can vary depending on the tumor's size and location.
Your genes may have an impact on how drugs work for you
For people with uveal cancer, genes can sometimes shape how well a medicine works and how likely side effects are, which can affect day-to-day things like fatigue, nausea, or how strongly treatment seems to help. One important example is that a newer medicine for advanced uveal cancer only works for people with a certain inherited immune-system type, so a simple blood test may be needed before treatment. This kind of gene-guided prescribing, sometimes called pharmacogenomics, is not used for every uveal cancer treatment, but it can matter for some medicines and can help the care team choose the safest and most useful option.
Pharmacological treatments
Medicines are not usually the main treatment for uveal cancer that is only in the eye, where radiation or surgery is more often used. Drug treatment becomes more important when the cancer has spread, especially to the liver or other parts of the body. Not everyone responds to the same medication in the same way. For many living with uveal cancer, treatment for metastatic uveal cancer may include newer immune-based drugs, standard immunotherapy, or less commonly chemotherapy.
Tebentafusp is a newer immune-based drug used for some adults with metastatic uveal melanoma, the most common type of uveal cancer. It is only an option for people who test positive for a specific tissue type called HLA-A*02:01, so testing is needed before treatment.
Drugs such as nivolumab, pembrolizumab, and ipilimumab help the immune system recognize and attack cancer cells. They may be used alone or in combination, although they often work less well in uveal cancer than they do in skin melanoma.
Chemotherapy medicines such as dacarbazine or temozolomide may sometimes be used when other options are not suitable. These drugs are generally less effective for uveal cancer, but they can still be considered in selected cases.
Some people may be offered newer targeted or immune treatments through clinical trials when standard medicines are limited. This can be an important option because research is still improving drug treatment for advanced uveal cancer.
Genetic influences
When uveal cancer happens, many living with it want to know whether genes had something to do with it. It’s natural to ask whether family history plays a role. In most cases, uveal cancer is linked to gene changes that develop in the eye’s pigment cells over time rather than a gene change inherited from a parent, so having no family history is common.
A small number of people have an inherited risk, most often related to a gene called BAP1, which can raise the chance of uveal cancer and some other cancers in the same family. Doctors may also test the tumor itself for gene changes because these results can help estimate how likely the cancer is to grow or spread, even though they do not always explain why it started. If there is a strong family history of uveal cancer, mesothelioma, kidney cancer, or several close relatives with unusual cancers, genetic counseling and genetic testing for uveal cancer may be worth discussing.
Is Uveal cancer genetic?
Genetics matter a lot in uveal cancer. Most cases are not inherited, but gene changes in the tumor help predict how it may behave and guide follow-up. Rarely, inherited changes can raise risk.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal part of human biology. Most do not directly affect health and simply reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link, not a certain diagnosis, particularly when several genes and environmental influences play a role. In other situations, though, one well-understood variant in a particular gene may be enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
For people living with uveal cancer, genetic test results can help explain why one treatment is offered over another and how closely doctors watch for spread. Doctors often test the tumor itself, because changes in genes such as BAP1, SF3B1, or EIF1AX can give clues about the chance of the cancer coming back or spreading, even though these results do not yet point to a standard targeted drug for most people. Not every difference in response is genetic, but these findings can shape follow-up plans, imaging schedules, and decisions about clinical trials. In advanced uveal cancer, one important genetic factor is a blood marker on immune cells called HLA-A*02:01; people need this marker to be eligible for tebentafusp, an immune therapy used for some metastatic cases. Genetics also matters because uveal cancer is biologically different from skin melanoma, so drugs that target common skin-melanoma changes, such as BRAF inhibitors, usually do not help. As genetic testing for uveal cancer treatment improves, it may help match more people to newer therapies and trials, alongside decisions based on tumor size, location, spread, and overall health.
Interactions with other conditions
Uveal cancer can sometimes be harder to spot in people who already have eye problems such as cataracts, glaucoma, or retinal disease, because blurred vision, flashes, or a new blind spot may be mistaken for something they have dealt with before. Many living with uveal cancer also need doctors to look closely at their overall health, since liver disease can matter if the cancer spreads there or if treatment decisions depend on how well the liver is working. Day-to-day, it can feel like one health issue amplifies the other, especially when vision changes, anxiety, or treatment side effects make it harder to manage other chronic conditions. Some treatments for uveal cancer may also need extra planning in people with autoimmune disease, bleeding problems, or serious heart or lung disease, because these conditions can affect which therapies are safest. If you are wondering about early symptoms of uveal cancer, it is worth remembering that common eye conditions can overlap with them, so new or changing symptoms should still be checked. Open communication with healthcare providers helps, especially when an eye specialist, cancer doctor, and primary care doctor all need to coordinate care.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Uveal cancer?
Several other eye problems can cause symptoms much like uveal cancer, including a retinal detachment, age-related macular degeneration, diabetic eye disease, eye inflammation, or bleeding inside the eye, all of which may lead to blurred vision, flashes, floaters, or a shadow in part of your sight. On an eye exam, a harmless freckle or mole inside the eye can also sometimes look similar at first, which is why a careful check by an eye specialist is so important.
History
People living with uveal cancer are often told it is a rare eye cancer, but the condition has been recognized in some form for a long time. Earlier doctors could only describe what they saw during an eye exam or after vision was already badly affected, so the disease was often found late. A person might have noticed blurred vision, a growing dark spot, or flashes of light, while the cause remained unclear.
Since the earliest days of medicine, efforts have been made to understand unusual growths inside the eye, although early descriptions were limited by the tools of the time. Once considered rare, now recognized as the most common cancer that starts inside the eye in adults, uveal cancer became easier to identify after major advances in eye imaging and microscopy in the 19th and 20th centuries. As medical science evolved, doctors learned that tumors arising from the colored or deeper middle layers of the eye were different from cancers on the eye surface and different from cancers that had spread there from elsewhere in the body.
That clearer picture changed care in a meaningful way. For many years, treatment often meant removing the whole eye because there were few reliable ways to control the tumor and protect vision. Over time, radiation treatments, laser-based approaches, and more precise surgery gave many living with uveal cancer options that could treat the cancer while preserving the eye in selected cases. This did not make the condition simple, but it gave patients and doctors more choices than earlier generations had.
Research also reshaped how doctors think about the future after diagnosis. Over time, specialists recognized that even when the eye tumor is treated successfully, uveal cancer can sometimes spread, especially to the liver, which is why follow-up care became such an important part of management. In recent decades, awareness has grown around the need for earlier diagnosis, better risk estimates, and treatments tailored to the individual tumor. Researchers later identified a genetic basis for differences between tumors, helping explain why some behave more aggressively than others, even though the history of uveal cancer began simply with careful observation of changes inside the eye.